Interv Akut Kardiol. 2010;9(2):81-85

Treatment and prevention of infective endocarditis

Radek Pelouch
I. interní klinika, FN Hradec Králové a LF UK v Hradci Králové

Infective endokarditis (IE) remains a very serious illness and neither the incidence nor the mortality have decreased in the past decades.

Eradication of microbes by antimicrobial drugs is the cornerstone of successful treatment. Antibiotic treatment should be targeted on the

basis of positive blood cultures. Cell wall inhibitors (β-lactams, glycopeptides) in combination with aminoglycosides are used the most

frequently. Surgery is indicated in approximately fifty percent of patiens because of severe complications (heart failure, uncontrolled

infection, prevention of systemic embolism). Because of the complexity of that illness, multispecialty approach is necessary. Updated

recommendations for prevention of IE have dramatically changed long-established practise. Antibiotic prophylaxis is now advised only

for the highest risk patients undergoing the highest risk dental procedures.

Keywords: infective endokarditis, treatment, prevention

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pelouch R. Treatment and prevention of infective endocarditis. Interv Akut Kardiol. 2010;9(2):81-85.
Download citation

References

  1. Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002; 288: 75-81. Go to original source... Go to PubMed...
  2. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005; 112: 69-75. Go to original source... Go to PubMed...
  3. San Roman JA, Lopez J, Vilacosta I, et al. Prognostic stratification of patiens with left-sided endocarditis determined at admission. Am J Med 2007; 120: 369e1-e7. Go to original source... Go to PubMed...
  4. Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004; 109: 1745-1749. Go to original source... Go to PubMed...
  5. Hasbun R, Vikram HR, Barakat LA, et al. Complicated leftsided native valve endocarditis in adults: risk classification for mortality. JAMA 2003; 289: 1933-1940. Go to original source... Go to PubMed...
  6. Wallace SM, Walton BI, Kharbanda RK, et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002; 88: 53-60. Go to original source... Go to PubMed...
  7. Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363: 139-149. Go to original source... Go to PubMed...
  8. Habib G. Management of infective endocarditis. Heart 2006; 92: 124-130. Go to original source... Go to PubMed...
  9. Beneš J, Gregor P, Mokráček A. Infekční endokarditida. Doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe. Cor Vasa 2007; 11(suppl): 106-120.
  10. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297: 1354-1361. Go to original source... Go to PubMed...
  11. Habib G, Hoen B, Torno P, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis. ESC guidelines. European Heart Journal 2009; 30: 2369-2413.
  12. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endokarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653-665. Go to original source... Go to PubMed...
  13. Guignard B, Entenza JM, Moreillon P. Beta-lactams against methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 2005; 5: 479-489. Go to original source... Go to PubMed...
  14. Vouillamoz J, Entenza JM, Feger C, et al. Quinupristin- dalfopristin combined with beta-lactams for treatment of experimental endokarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother 2000; 44: 1789-1795. Go to original source... Go to PubMed...
  15. Olaison L, Schadewitz K. Enterococcal endocarditis in Sweden, 1995-1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 2002; 34: 159-166. Go to original source... Go to PubMed...
  16. Das M, Badley AD, Cockerill FR, et al. Infective endokarditis caused by HACEK microorganisms. Annu Rev Med 1997; 48: 25-33. Go to original source... Go to PubMed...
  17. Paturel L, Casalta JP, Habib G, et al. Actinobacillus Atinomycetemcomitans endocarditis. Clin Microbiol Infect 2004; 10: 98-118. Go to original source... Go to PubMed...
  18. Garzoni C, Nobre VA, Garbino J. Candida parapsilosis endocarditis: a comparative review of the literature. Eur J Clin Microbiol Infect Dis 2007; 26: 915-926. Go to original source... Go to PubMed...
  19. Lye DC, Hughes A, O'Brien D, et al. Candida glabrata prosthetic valve endokarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. Eur J Clin Microbiol Infect Dis 2005; 24: 753-755. Go to original source... Go to PubMed...
  20. Tornos P, Iung B, Permanyer-Miralda G, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart 2005; 91: 571-575. Go to original source... Go to PubMed...
  21. Delay D, Pellerin M, Carrier M, et al. Immediate and longterm results of valve replacement for native and prosthetic valve endocarditis. Ann Thorac Surg 2000; 70: 1219-1223. Go to original source... Go to PubMed...
  22. Alexiou C, Langley SM, Stafford H, et al. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 2000; 69: 1448-1454. Go to original source... Go to PubMed...
  23. Kaiser SP, Melby SJ, Zierer A, et al. Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg 2007; 83: 30-35. Go to original source... Go to PubMed...
  24. David TE, Gavra G, Feindel CM, et al. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg 2007; 133: 144-149. Go to original source... Go to PubMed...
  25. Ruttmann E, Legit C, Poelzl G, et al. Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg 2005; 130: 765-771. Go to original source... Go to PubMed...
  26. Thuny F, Beurtheret S, Gariboldi V, et al. Outcome after surgical treatment performed within the first week of antimicrobial therapy during infective endocarditis: a prospective study. Arch Cardiovasc Dis 2008; 101: 687-695. Go to original source... Go to PubMed...
  27. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis. Diagnosis, antimicrobial therapy, and management of comlications. AHA scientific statement. Circulation 2005; 111: e394-e433. Go to original source... Go to PubMed...
  28. Thuny F, Di Salvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005; 112: 69-75. Go to original source... Go to PubMed...
  29. Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991; 114: 635-640. Go to original source... Go to PubMed...
  30. Vilacosta I, Graupner C, San Roman JA, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002; 39: 1489-1495. Go to original source... Go to PubMed...
  31. Lopes S, Calvinho P, de Oliveira F, et al. Allograft aortic root replacement in complex prosthetic endocarditis. Eur J Cardiothorac Surg 2007; 32: 126-130; discussion 131-132. Go to original source... Go to PubMed...
  32. Sabik JF, Lytle BW, Blackstone EH, et al. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 2002; 74: 650-659; discussion 659. Go to original source... Go to PubMed...
  33. Avierinos JF, Thuny F, Chalvignac V, et al. Surgical treatment of aktive aortic endocarditis: homografts are not the cornerstone of outcome. Ann Thorac Surg 2007; 84: 1935-1942. Go to original source... Go to PubMed...
  34. Krasopoulos G, David TE, Armstrong S. Custom-tailored valved conduit for complex aortic root disease. J Thorac Cardiovasc Surg 2008; 135: 3-7. Go to original source... Go to PubMed...
  35. Guerra JM, Tornos MP, Permanyer-Miralda G, et al. Long term results of mechanical prostheses for treatment of active infective endocarditis. Heart 2001; 86: 63-68. Go to original source... Go to PubMed...
  36. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268. Go to original source... Go to PubMed...
  37. Forner L, Larsen T, Kilian M, et al. Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol 2006; 33: 401-407. Go to original source... Go to PubMed...
  38. Roberts GJ. Dentists are innocent ! 'Everyday' bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children. Pediatr Cardiol 1999; 20: 317-325. Go to original source... Go to PubMed...
  39. Duval X, Leport C. Prophylaxis of infective endocarditis: current tendencies, continuing controversies. Lancet Infect Dis 2008; 8: 225-232. Go to original source... Go to PubMed...
  40. Wilson W, Taubert KA, Gewitz M. Prevention of infective endocarditis. Guidelines from the American heart association. Circulation 2007; 116: 1736-1754. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.